|
[1]
|
柳鹏, 李勇. 人参皂苷生物活性的研究进展[J]. 中国生育健康杂志, 2004, 15(5): 317-319.
|
|
[2]
|
Chen, X.J., Zhang, X.J., Shui, Y.M., Wan, J.B. and Gao, J.L. (2016) Anticancer Activities of Protopanaxadiol- and Protopanaxatriol-Type Ginsenosides and Their Metabolites. Evidence-Based Complementary and Alternative Medicine, 2016, Article ID: 5738694.
|
|
[3]
|
姚婵, 来茂德. 上皮间质转化(EMT)及其分子机制[J]. 国际遗传学杂志, 2006, 29(4): 290-294.
|
|
[4]
|
Kalluri, R. (2009) EMT: When Epithelial Cells Decide to Become Mesenchymal-Like Cells. Journal of Clinical Investigation, 119, 1417-1419. [Google Scholar] [CrossRef]
|
|
[5]
|
胡倩雯, 韩向晖. 中药干预肿瘤及纤维化疾病上皮间充质转化的研究进展[J]. 云南中医中药杂志, 2015, 36(3): 69-72.
|
|
[6]
|
Liu, T., Zhao, L., Zhang, Y., et al. (2014) Ginsenoside 20(S)-Rg3 Targets HIF-1α to Block Hypoxia-Induced Epithelial-Mesenchymal Transition in Ovarian Cancer Cells. PLOS ONE, 9, e103887. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Li, J., Lu, J.J., Ye, Z.X., et al. (2017) 20(S)-Rg 3 Blocked Epi-thelial-Mesenchymal Transition through DNMT3A/miR- 145/FSCN1 in Ovarian Cancer. Oncotarget, 8, 53375-53386. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Li, J., Zhang, S.L., Pei, M.L., et al. (2018) FSCN1 Promotes Epi-thelial-Mesenchymal Transition through Increasing Snail1 in Ovarian Cancer Cells. Cellular Physiology and Biochemis-try, 49, 1766-1777. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Wang, C.Z., Anderson, S., Du, W., et al. (2016) Red Ginseng and Cancer Treatment. Chinese Journal of Natural Medicines, 14, 7-16.
|
|
[10]
|
Zhou, Q.L., Zhu, D.N., Yang, X.W., et al. (2018) De-velopment and Validation of a UFLC-MS/MS Method for Simultaneous Quantification of Sixty-Six Saponins and Their Six Aglycones: Application to Comparative Analysis of Red Ginseng and White Ginseng. Journal of Pharmaceutical and Biomedical Analysis, 159, 153-165. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Chen, Z., Wei, X., Shen, L., et al. (2019) 20(S)-ginsenoside-Rg3 Reverses Temozolomide Resistance and Restrains Epithelial-Mesenchymal Transition Progression in Glioblastoma. Cancer Science, 110, 389-400. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Qiu, R., Qian, F., Wang, X., et al. (2019) Targeted Delivery of 20(S)-Ginsenoside Rg3-Based Polypeptide Nanoparticles to Treat Colon Cancer. Biomed Microdevices, 21, 18. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Wang, X.J., Zhou, R.J., Zhang, N., et al. (2019) 20(S)-ginsenoside Rg3 Sensitizes Human Non-Small Cell Lung Cancer Cells to Icotinib through Inhibition of Autophagy. European Journal of Pharmacology, 850, 141-149. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Peng, Y., Zhang, R., Yang, X., et al. (2019) Ginsenoside Rg3 Suppresses the Proliferation of Prostate Cancer Cell Line PC3 through ROS-Induced Cell Cycle Arrest. Oncology Letters, 17, 1139-1145. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Guo, Y.H., Kuruganti, R. and Gao, Y. (2019) Recent Advances in Ginsenosides as Potential Therapeutics against Breast Cancer. Current Topics in Medicinal Chemistry, 19, 2334-2347. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Bian, S., Zhao, Y., Li, F., et al. (2019) 20(S)-ginsenoside Rg3 Promotes HeLa Cell Apoptosis by Regulating Autophagy. Molecules, 24, 3655. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
董方言. 现代实用中药新剂型新技术[M]. 北京: 人民卫生出版社, 2001: 363-378.
|
|
[18]
|
Mundargi, R.C., Babu, V.R., Rangaswamy, V., et al. (2008) Nano/Micro Technologies for Delivering Macromolecular Theapeutics Using Poly(D, L-lactide-co-glycolide)and Its Derivatives. Journal of Controlled Release, 125, 193-209. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Lu, J.M., Wang, X., Marin-Muller, C., et al. (2009) Current Advances in Research and Clinical Applications of PLGA Based Nanotecheology. Expert Review of Molecular Diagnos-tics, 9, 325-341. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
杨华, 易红. 我国微乳技术在药学领域中的研究进展[J]. 中国新药杂志, 2006, 15(10): 764-769.
|
|
[21]
|
胡译丽, 程国华. 抗肿瘤药物靶向制剂的研究进展[J]. 今日药学, 2021, 21(5): 317-320.
|